BCR and prostate cancer: Therefore, this study employed the definition of the nationwide, prospective Japanese Prostate Cancer Outcomes Study (J-POPS) of BCR after RT, in which a PSA of >1.0 ng/mL for at least three measurements is considered to identify BCR in a patient [15].